Partner Content Partner Content Orphan medicines, advances, access and affordability LONDON, UNITED KINGDOM, April 19th 2017:
News Call for focus on NHS during snap election Pharma calls for focus on health service as nation goes to the polls.
News NICE rejects Opdivo in head and neck cancer – before it gain... England and Wales’ cost effectiveness watchdog NICE has rejected Opdivo for use against advanced head and neck cancer in draft guidance – before the drug has even been given final Euro
Views & Analysis How healthcare professionals engage NICE online NICE is reaching out and engaging more via social media.
News Hospitals should be fined for failing to innovate - report Government must get tough to encourage innovation, say peers.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News Neuralink unveils trial linking brain implant to robotic arm Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
